Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Figures corrected NBB
Corrected annual account filed for 2023.
Financials
Financial year 2024
SOCIETE PHARMACEUTIQUE DE GESTION from Elsene, company number BE0864721445, closed financial year 2024 with a result of € 23,854 after tax. For that financial year SOCIETE PHARMACEUTIQUE DE GESTION recorded a gross margin of € 41,637 and equity of € 50,064. Compared with financial year 2023, the result moved from € 8,288 to € 23,854. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2025.
€ 50,064
▼ 4% vs 2023
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 23,854
▲ 188% vs 2023
Profit after tax over the fiscal year.
€ 73,482
▼ 6% vs 2023
Cash and bank balances on the last day of the fiscal year.
€ 26,000 paid out
More than the year’s profit went to the shareholders; reserves fell.
People and assets in 2024
≈ 1
No payroll staff. One director, so that person most likely runs the business.
€ 10,243
▼ 35% vs 2023
Book value of vehicles, furniture and equipment.
Debts at end 2024
None
No bank loans on the last day of the fiscal year.
€ 8,269
▲ 297% vs 2023
Supplier invoices still open on the last day of the fiscal year.
€ 19,902
▼ 12% vs 2023
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2021 | 2022 | 2023 | 2024 | Change 2023 → 2024 | |
|---|---|---|---|---|---|
| Gross margin | € 59,722 | € 38,185 | € 21,469 | € 41,637 | ▲ 94% |
| Profit after taxes | € 41,166 | € 17,204 | € 8,288 | € 23,854 | ▲ 188% |
| Equity | € 68,146 | € 65,350 | € 52,210 | € 50,064 | ▼ 4% |
| Total debts | € 68,654 | € 42,920 | € 46,177 | € 48,171 | ▲ 4% |
| Cash | € 32,178 | € 61,169 | € 78,196 | € 73,482 | ▼ 6% |
| Retained profit | € 61,946 | € 59,150 | € 46,010 | € 43,864 | ▼ 5% |
| Dividend | € 0 | € 20,000 | € 21,429 | € 26,000 | ▲ 21% |
| Balance sheet total | € 136,801 | € 108,270 | € 98,387 | € 98,235 |
Key figures of SOCIETE PHARMACEUTIQUE DE GESTION, fiscal years 2021 to 2024, from the annual accounts filed with the National Bank of Belgium.The annual account for fiscal year 2025 has not been filed yet; it was expected before 31 July 2026.
What happened to SOCIETE PHARMACEUTIQUE DE GESTION?
What happened at SOCIETE PHARMACEUTIQUE DE GESTION in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2024: profit of € 23,854 (▲ 188% vs 2023). filed late Source: NBB ↗
- Start of the company according to the CBE. KBO
- New establishment in Elsene. KBO
In short
From € 41,166 profit in 2021 to € 23,854 profit in 2024.
Paid € 44,741 in corporate taxes since 2021.
Best year ever: 2021, with € 41,166 profit.
Paid out € 67,429 in dividends to the owners in total.
A new publication or filing at SOCIETE PHARMACEUTIQUE DE GESTION? We notify you, reason included.
Follow SOCIETE PHARMACEUTIQUE DE GESTIONDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind SOCIETE PHARMACEUTIQUE DE GESTION is Marie-Jeanne DEVRIENDT.
Directors
According to the 2024 annual accounts
Marie-Jeanne DEVRIENDT
GERANT
Establishments
Establishment units
Physical locations of this company
Lariksenstraat 2
1050 Elsene
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0864.721.445
- VAT number
- BE 0864.721.445
- Registered office
- Lariksenstraat 2, 1050 Elsene
- Names & denominations
- SOCIETE PHARMACEUTIQUE DE GESTION · SOPHAGEST
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 14 April 2004
- Peppol
- Active · Active since 22 Oct 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers